title: Influence of postoperative enteral nutrition on cellular immunity. A random double-blinded placebo controlled clinical trial.
abstract: OBJECTIVE
  The aim of this study was to discover if the cellular immunological response is different in patients receiving early postoperative enteral nutrition compared to patients who only receive "water".
  
  
  METHODS
  In a random double-blind prospective trial, 30 patients received Nutridrink® and 30 patients received placebo (water) through a nasoduodenal tube from the day of operation to the fourth postoperative day. Leukocyte differential count was examined preoperatively, and on the first, third, and seventh postoperative days. Subpopulations of lymphocytes were flow cytometrically analysed. IL-1ra and soluble IL-2R were investigated by use of an enzyme-linked immunosorbent assay.
  
  
  RESULTS
  In the enteral nutrition group, a significantly larger number of circulating monocytes and NK-cells and a significantly larger expression of HLA-DR were found. In the nutrition group, a tendency to larger numbers of T-lymphocyte subpopulations was found. No difference in IL-1ra and soluble IL-2R was found between the groups.
  
  
  CONCLUSIONS
  Early postoperative enteral nutrition has an important influence on the immediate unspecific cellular immunity and an activating effect on the specific cellular immunity compared to "no food".
authors.affiliation: Department of Surgery, Hillerød University Hospital, Hillerød, Denmark. rabeho@hih.regionh.dk
authors.forename: R
authors.initials: R
authors.lastname: Beier-Holgersen
authors.forename: B
authors.initials: B
authors.lastname: Brandstrup
mesh_terms: D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D004311:Double-Blind Method; D004750:Enteral Nutrition / Q000379:methods*; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000276:immunology*; D053590:Interleukin 1 Receptor Antagonist Protein / Q000276:immunology; D007958:Leukocyte Count; D016131:Lymphocyte Subsets / Q000276:immunology; D008297:Male; D008875:Middle Aged; D010919:Placebos; D011182:Postoperative Care / Q000379:methods*; D015375:Receptors, Interleukin-2 / Q000276:immunology; D012995:Solubility
chemical_list: D053590:Interleukin 1 Receptor Antagonist Protein; D010919:Placebos; D015375:Receptors, Interleukin-2
references.citation: JPEN J Parenter Enteral Nutr. 1999 Nov-Dec;23(6):314-20
references.pmid: 10574478
references.citation: Acta Anaesthesiol Scand. 2002 Apr;46(4):405-10
references.pmid: 11952441
references.citation: Br J Surg. 1985 Oct;72(10):771-6
references.pmid: 2412626
references.citation: Gut. 1996 Dec;39(6):833-5
references.pmid: 9038665
references.citation: Surg Clin North Am. 1983 Apr;63(2):245-61
references.pmid: 6344272
references.citation: Sb Lek. 2002;103(2):273-82
references.pmid: 12688152
references.citation: Scand J Gastroenterol. 1999 Jan;34(1):98-102
references.pmid: 10048740
references.citation: Am J Clin Nutr. 2001 Feb;73(2):323-32
references.pmid: 11157331
references.citation: Arch Surg. 1999 Dec;134(12):1309-16
references.pmid: 10593328
references.citation: Clin Nutr. 2000 Dec;19(6):407-12
references.pmid: 11104591
references.citation: Surg Today. 2003;33(8):565-70
references.pmid: 12884092
references.citation: Arch Surg. 2002 Feb;137(2):174-80
references.pmid: 11822956
references.citation: Crit Care Med. 1995 Apr;23(4):652-9
references.pmid: 7536138
references.citation: Dig Surg. 1998;15(2):102-4
references.pmid: 9845570